Vaccines and patents in Covid-19 times: An impossible coexistence?
The rapid development of Covid-19 vaccines is a great success for contemporary science. The challenge now is to ensure access to vaccination for the entire world population as quickly as possible
The IMF, several international institutions and a number of governments have recently called for a “whatever it takes” approach to tackle the ongoing Covid-19 pandemic.
There is a structural underproduction of vaccines worldwide, which magnifies the social and economic costs of the crisis.
The current intellectual property rights regime may be an obstacle to the broadest possible production and diffusion of vaccines, particularly for poorer countries. In this workshop we will discuss the role of property rights in the field of vaccines from a scientific, legal and economic perspective.
A workshop organised within the activities of the H2020 project GROWINPRO
Fabrizio Chiodo - Researcher CNR-ICB Pozzuoli and Finlay Institute of Vaccines Cuba
Giovanni Dosi - Professor of Economics, Scuola Superiore Sant’Anna
Margaret K. Kyle - Professor of Economics, CERNA, MINES ParisTech
Paul Nightingale - Professor of Strategy, University of Sussex
Andrea Roventini - Professor of Economics, Scuola Superiore Sant’Anna & GROWINPRO’s PI